Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Executive or director change
  2. 4 Grant or award GENERAL COUNSEL acquired 435,834 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award SVP, Finance acquired 11,401 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Director sold 10,000 shares at $4.29 ($42,855)
  7. 144 Insider Sale of Securities
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SC 13G Stake Amended Statement of Ownership
  11. 144 Insider Sale of Securities
  12. 8-K Event Other events
  13. 144 Insider Sale of Securities
  14. 4 Grant or award Director acquired 74,561 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 59,649 shares (grant or award)
  17. 4 Grant or award Director acquired 74,561 shares (grant or award)
  18. 4 Grant or award Director acquired 74,561 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 30 · 587 filings